• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Tesamorelin Uses, Side Effects & Warnings

Uses

Tesamorelin is used to treat obesity in adults. It helps reduce weight by affecting the hypothalamus, a part of the brain that controls hunger and satiety signals.

Side Effects

Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- headache
- fatigue

Rare but serious side effects should be reported to a healthcare provider, such as:
- Changes in heart rhythm (e.g., palpitations)
- Severe stomach pain or discomfort
- Yellowing of the skin or eyes (signs of liver issues)

Warnings

Tesamorelin should not be used by individuals with a history of certain conditions, such as:
- Concurrent use of other weight loss products
- Uncontrolled high blood pressure
- History of heart-related problems
- Pregnant or breastfeeding women
Always consult a healthcare provider before starting any medication.

Tesamorelin

Tesamorelin is a synthetic peptide hormone that mimics the action of growth hormones (GH) by stimulating the release of GH from the pituitary gland. It is often used in the treatment of growth hormone deficiency (GHD), particularly in adults who cannot produce sufficient amounts of endogenous GH. Tesamorelin works by binding to ghrelin receptors, which then signal the pituitary gland to release GH into the bloodstream.

Tesamorelin side effects

Like many medications, tesamorelin may cause side effects in some individuals. Common side effects include:

-

Nausea and vomiting (often mild)

-

Injection site reactions, such as redness, swelling, or itching

-

Dizziness or headache

-

Abdominal discomfort

-

Xerophthalmia (dry eyes)

These side effects are usually mild and temporary. However, you should inform your healthcare provider if they persist or become bothersome.

Related/similar drugs

Tesamorelin is part of a class of medications known as growth hormone-releasing peptides (GHRPs). Other similar drugs include:

-

Egrifta: A form of tesamorelin, used for the treatment of GHD in adults

-

Myalept: A synthetic analog of ghrelin that also stimulates GH release

-

Mounjaro: Another growth hormone-releasing peptide used for GHD

-

Genotropin: A synthetic GH analog used to treat growth hormone deficiency

-

Humatrope: A recombinant DNA-derived human GH, similar in function to tesamorelin

-

Macrilen: Another GHRP used for the treatment of obesity and GHD

-

Ngenla: A synthetic analog of ghrelin

-

Norditropin: A synthetic GH, often used in the treatment of growth hormone deficiency

-

Metreleptin: A synthetic peptide that mimics GH-releasing factors

Warnings

Before taking tesamorelin, it is important to inform your healthcare provider if you have any of the following:

-

Pregnancy or breastfeeding (Safety in pregnancy has not been established)

-

History of allergies to synthetic peptides or GH products

-

Abnormalities or conditions that affect the gastrointestinal system (e.g., ulcers, esophageal reflux)

-

Conditions where growth hormone levels are naturally high (e.g., certain types of cancer or acromegaly)

Tesamorelin should be taken under strict medical supervision. Injection site reactions and other side effects can occur, so proper administration is crucial.

How tesamorelin given?

Tesamorelin is typically administered as a subcutaneous injection. The dosage and frequency of injection will be determined by your healthcare provider based on your individual needs. Common starting doses for adults may range from 1 mg to 3 mg per day, divided into one or two injections.

Tesamorelin dosing information

The dosage of tesamorelin may need to be adjusted based on factors such as:

-

Your current level of growth hormone

-

Your age and health status

-

Response to treatment

For adults, the typical dose is 1 mg to 3 mg per day, often divided into two injections. For children, dosing may vary significantly based on their growth needs and weight.

What happens if I miss a dose?

If you miss a scheduled dose of tesamorelin, take it as soon as you remember, but do not exceed the recommended dosage. Missing doses can lead to inadequate GH stimulation, potentially affecting your treatment outcome.

What happens if I overdose?

Overdosing with tesamorelin can increase the risk of side effects, including nausea, injection site reactions, and dizziness. If you suspect an overdose, contact your healthcare provider immediately.

What should I avoid while using tesamorelin?

Avoid consuming alcohol while on tesamorelin, as it may interfere with its absorption or effectiveness. Also, inform your doctor if you are taking other medications, including over-the-counter drugs and supplements, as they may interact with tesamorelin.

What other drugs will affect tesamorelin?

Tesamorelin may not be compatible with all other medications. Inform your healthcare provider about any drugs you are taking, including:

-

Certain diuretics or blood pressure medications

-

Metabolism-altering drugs (e.g., enzyme inhibitors or inducers)

-

Growth hormone-releasing peptide analogs

-

Pituitary hormones

Your healthcare provider will help you determine if tesamorelin is safe to use with your current medications.

Tesamorelin Biosimilars

While tesamorelin is a biologically derived compound, biosimilars (generic versions of tesamorelin) are now available. These biosimilars may offer cost savings and provide an alternative for patients who cannot afford the brand-name product. However, always consult your healthcare provider before switching to a biosimilar or generic version to ensure it is appropriate for your condition.

Reference products

Tesamorelin is derived from somatostatin and ghrelin. The reference product used as the basis for synthetic tesamorelin is derived from these peptides, ensuring that synthetic versions are biologically equivalent to the naturally occurring hormone.

More about tesamorelin

Tesamorelin is also known by its trade names Egrifta and Myalept. It is classified as a growth hormone-releasing peptide (GHRP) and is primarily used in the treatment of obesity-related GHD in adults. Its mechanism of action involves stimulating the pituitary gland to release GH, which can help promote fat loss and support muscle growth.

Patient resources

For more information about tesamorelin, including patient assistance programs and support groups, visit your healthcare provider's office or consult a trusted medical resource. Additionally, many pharmaceutical companies provide patient-friendly materials to help you understand your treatment options and manage side effects.

Other brands

Tesamorelin may be sold under other brand names, including Egrifta and Myalept. These brand names may refer to different forms or formulations of the drug, so always check with your healthcare provider to ensure you are using the correct product for your condition.

Professional resources

For detailed medical information about tesamorelin, consult professional resources such as clinical guidelines, prescribing information, and studies. Your healthcare provider can also provide additional insights based on your specific health needs and treatment goals.

Further information

For more in-depth coverage of tesamorelin, including its mechanism of action, clinical trials, and patient education materials, refer to reputable medical websites or databases. Always consult a healthcare professional before making any changes to your treatment plan based on the information provided.

Sources: https://jbhnews.com .